एस्टोनिया - एस्टोनियाई - Ravimiamet

sandoz pharmaceuticals d.d. - bendamustiin - infusioonilahuse kontsentraadi pulber - 2,5mg 1ml 25mg 5tk; 2,5mg 1ml 100mg 5tk; 2,5mg 1ml 25mg 20tk; 2,5mg 1ml 25mg 10tk; 2,5mg 1ml 100mg 1tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

krka d.d. novo mesto - erlotiniib - õhukese polümeerikattega tablett - 100mg 60tk; 100mg 30tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

krka d.d. novo mesto - erlotiniib - õhukese polümeerikattega tablett - 150mg 30tk

एस्टोनिया - एस्टोनियाई - Ravimiamet

krka d.d. novo mesto - erlotiniib - õhukese polümeerikattega tablett - 25mg 30tk

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - split gripiviirus, inaktiveeritud, mis sisaldab antigeeni: a / vietnam / 1194/2004 (h5n1) nagu tüvi (nibrg-14) - influenza, human; immunization; disease outbreaks - vaktsiinid - aktiivne immuniseerimine gripiviiruse a viiruse h5n1 alatüübi vastu. see näidustus põhineb immunogenicity andmeid tervisliku teemasid, alates vanusest 18 aastat aastast pärast manustamist kaks annust vaktsiini, mis on valmistatud a/vietnam/1194/2004 nibrg-14 (h5n1) (vt lõik 5. prepandemic gripi vaktsiin (h5n1) (split virion, inaktiveeritud, adjuvanted) glaxosmithkline biologicals 3. 75 µg tuleks kasutada vastavalt euroopa liidu arendus.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - a / indonesia / 05/2005 (h5n1) sarnane tüvi (pr8-ibcdc-rg2) - influenza, human; immunization; disease outbreaks - vaktsiinid - aktiivne immuniseerimine gripiviiruse h5n1 alatüübi vastu. see näidustus põhineb immunogenicity andmeid tervisliku teemasid, alates vanusest 18 aastat aastast pärast manustamist kaks annust vaktsiini, mis on valmistatud alatüübi h5n1 tüve. prepandrix tuleks kasutada vastavalt euroopa liidu arendus.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

biomarin international limited - vosoritide - achondroplasia - narkootikumid luuhaiguste raviks - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastilised ained - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

यूरोपीय संघ - एस्टोनियाई - EMA (European Medicines Agency)

lipomed gmbh - talidomiid - mitu müeloomit - immunosupressandid - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.